View in EDS PDF Full Text

Pasireotide can induce sustained decreases in urinary cortisol and provide clinical benefit in patients with Cushing's disease: results from an open-ended, open-label extension trial.

Saved in:
Bibliographic Details
Title: Pasireotide can induce sustained decreases in urinary cortisol and provide clinical benefit in patients with Cushing's disease: results from an open-ended, open-label extension trial.
Authors: Schopohl J; Medizinische Klinik IV, University of Munich, Munich, Germany., Gu F, Rubens R, Van Gaal L, Bertherat J, Ligueros-Saylan M, Trovato A, Hughes G, Salgado LR, Boscaro M, Pivonello R
Corporate Authors: Pasireotide B2305 Study Group
Source: Pituitary [Pituitary] 2015 Oct; Vol. 18 (5), pp. 604-12.
Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Kluwer Academic Publishers Country of Publication: United States NLM ID: 9814578 Publication Model: Print Cited Medium: Internet ISSN: 1573-7403 (Electronic) Linking ISSN: 1386341X NLM ISO Abbreviation: Pituitary Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 25537481
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Pasireotide can induce sustained decreases in urinary cortisol and provide clinical benefit in patients with Cushing's disease: results from an open-ended, open-label extension trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Schopohl+J%22">Schopohl J</searchLink>; Medizinische Klinik IV, University of Munich, Munich, Germany.<br /><searchLink fieldCode="AU" term="%22Gu+F%22">Gu F</searchLink><br /><searchLink fieldCode="AU" term="%22Rubens+R%22">Rubens R</searchLink><br /><searchLink fieldCode="AU" term="%22Van+Gaal+L%22">Van Gaal L</searchLink><br /><searchLink fieldCode="AU" term="%22Bertherat+J%22">Bertherat J</searchLink><br /><searchLink fieldCode="AU" term="%22Ligueros-Saylan+M%22">Ligueros-Saylan M</searchLink><br /><searchLink fieldCode="AU" term="%22Trovato+A%22">Trovato A</searchLink><br /><searchLink fieldCode="AU" term="%22Hughes+G%22">Hughes G</searchLink><br /><searchLink fieldCode="AU" term="%22Salgado+LR%22">Salgado LR</searchLink><br /><searchLink fieldCode="AU" term="%22Boscaro+M%22">Boscaro M</searchLink><br /><searchLink fieldCode="AU" term="%22Pivonello+R%22">Pivonello R</searchLink>
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22Pasireotide+B2305+Study+Group%22">Pasireotide B2305 Study Group</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229814578%22">Pituitary</searchLink> [Pituitary] 2015 Oct; Vol. 18 (5), pp. 604-12.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Kluwer+Academic+Publishers%22">Kluwer Academic Publishers </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9814578 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1573-7403 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%221386341X%22">1386341X </searchLink><i>NLM ISO Abbreviation: </i>Pituitary <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=25537481
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s11102-014-0618-1
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 604
    Titles:
      – TitleFull: Pasireotide can induce sustained decreases in urinary cortisol and provide clinical benefit in patients with Cushing's disease: results from an open-ended, open-label extension trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Schopohl J
      – PersonEntity:
          Name:
            NameFull: Gu F
      – PersonEntity:
          Name:
            NameFull: Rubens R
      – PersonEntity:
          Name:
            NameFull: Van Gaal L
      – PersonEntity:
          Name:
            NameFull: Bertherat J
      – PersonEntity:
          Name:
            NameFull: Ligueros-Saylan M
      – PersonEntity:
          Name:
            NameFull: Trovato A
      – PersonEntity:
          Name:
            NameFull: Hughes G
      – PersonEntity:
          Name:
            NameFull: Salgado LR
      – PersonEntity:
          Name:
            NameFull: Boscaro M
      – PersonEntity:
          Name:
            NameFull: Pivonello R
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 10
              Text: 2015 Oct
              Type: published
              Y: 2015
          Identifiers:
            – Type: issn-electronic
              Value: 1573-7403
          Numbering:
            – Type: volume
              Value: 18
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Pituitary
              Type: main
ResultId 1